Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Fe.O4S.7H2O |
| Molecular Weight | 278.015 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.O.O.[Fe++].[O-]S([O-])(=O)=O
InChI
InChIKey=SURQXAFEQWPFPV-UHFFFAOYSA-L
InChI=1S/Fe.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Fe |
| Molecular Weight | 55.845 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false
Sources: http://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfhttps://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502http://www.foodchemadditives.com/products/Ferrous-Lactatehttps://www.ncbi.nlm.nih.gov/pubmed/14116934DOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false
There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
| Curative | RADIOGARDASE Approved UseInsoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. Launch Date2003 |
|||
PubMed
| Title | Date | PubMed |
|---|---|---|
| Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example. | 2017-07-05 |
|
| Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle. | 2017-05-01 |
|
| Atomic Layer Deposition of Iron Sulfide and Its Application as a Catalyst in the Hydrogenation of Azobenzenes. | 2017-03-13 |
|
| Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes. | 2015-06-22 |
|
| A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
|
| Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows. | 2013-07 |
|
| Tolerability of different oral iron supplements: a systematic review. | 2013-04 |
|
| Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. | 2011-06-10 |
|
| The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. | 2010-12 |
|
| Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study. | 2009-11-15 |
|
| Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. | 2009 |
|
| Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis. | 2007 |
|
| Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe. | 1997-10 |
|
| [Historical notes on the therapy of depression]. | 1986-11-22 |
|
| [FERROUS ASPARTATE IN THERAPY]. | 1964-01-01 |
|
| Clinical appraisal of drugs with special reference to a new chelate hematinic. | 1957-07-11 |
|
| [Ferrous lactate as an oral iron preparation for therapeutic use]. | 1954-11-27 |
|
| THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA. | 1937-07 |
|
| FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS. | 1932-11-11 |
|
| THE ADMINISTRATION OF FERROUS IODIDE AND LINOLEIC ACID TO RATS DEPRIVED OF VITAMIN A. | 1932-09-30 |
|
| FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS. | 1932-07-01 |
Sample Use Guides
Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:12 GMT 2025
by
admin
on
Mon Mar 31 17:58:12 GMT 2025
|
| Record UNII |
39R4TAN1VT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
50502
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
||
|
WHO-ATC |
B03AD03
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
||
|
CFR |
21 CFR 184.1315
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
||
|
LIVERTOX |
407
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
||
|
WHO-VATC |
QB03AA07
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
||
|
WHO-ATC |
B03AA07
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
||
|
WHO-VATC |
QB03AD03
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1270355
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
DTXSID9040344
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
SUB126949
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
75832
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
7782-63-0
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
62662
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
FERROUS SULFATE
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | Description: Exsiccated Ferrous sulfate is a greyish white powder; Ferrous sulfate heptahydrate has pale blue-green prisms or isa pale green, crystalline powder; both forms are odourless.Solubility: Exsiccated Ferrous sulfate is slowly but almost completely soluble in carbon-dioxide-free water R; practically insolublein ethanol (~750 g/l) TS. Ferrous sulfate heptahydrate is freely soluble in water; very soluble in boiling water; practically insolublein ethanol (~750 g/l) TS.Category. Haemopoietic (iron-deficiency anaemia).Storage: Ferrous sulfate should be kept in a well-closed container.Labelling: The designation on the container of Ferrous sulfate should state whether the substance is in the exsiccated form or isthe heptahydrate. | ||
|
C29049
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
4528
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
SUB21826
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
100000087595
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
C020748
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
39R4TAN1VT
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200830
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
75836
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
39R4TAN1VT
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
24947
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | RxNorm | ||
|
Ferrous sulfate
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
SUB13877MIG
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
m5354
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | Merck Index | ||
|
DBSALT002666
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Mon Mar 31 17:58:12 GMT 2025 , Edited by admin on Mon Mar 31 17:58:12 GMT 2025
|
CONCEPT | Dietary Supplement |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|